EPISODE · Apr 11, 2023 · 15 MIN
BONUS: Mifepristone On Trial: An Unprecedented Overreach
from Public Health On Call · host Johns Hopkins Bloomberg School of Public Health
Dr. Raegan McDonald Mosley, an obstetrician-gynecologist and CEO of Power to Decide, returns to the podcast to talk with Dr. Josh Sharfstein about the Texas case that invalidated FDA approval of the abortion medication mifepristone. They discuss what the ruling might mean in the short term and the broader implications for reproductive health, FDA approval of other drugs, and the field of medicine.
Embed this episode
NOW PLAYING
BONUS: Mifepristone On Trial: An Unprecedented Overreach
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.